Variant Bio: Evotech and Variant Bio partner to develop fibrosis treatment
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
Read full article »
Variant Bio is a Washington-based biotechnology company that develops and commercializes genomic therapies for the treatment of infectious diseases.
Read more